Corporates - Autoimmune Diseases

A total of 338 corporates are partnering with Digital Health ventures that are operating within the Autoimmune Diseases therapeutic area.

These stakeholders have closed a total of 426 partnerships. Their partner Digital Health ventures have an average maturity score of 289.5. Companies within this space partner primarily with ventures within the Research Solutions Digital Health cluster.

Last Updated: August 15, 2026

Corporates

Result: 338

Corporate Name	Number of Partners	Partners
Pfizer	9	WeDoctor (微医), GeneDX, asddswdsfd , asddswdsfd View All
AstraZeneca	7	WeDoctor (微医), Immunai, asddswdsfd , asddswdsfd View All
Mayo Clinic	7	Atropos Health, Inspire, asddswdsfd , asddswdsfd View All
Johnson & Johnson Innovative Medicine	7	GeneDX, Atropos Health, asddswdsfd , asddswdsfd View All
GSK	6	WeDoctor (微医), Genomics PLC, asddswdsfd , asddswdsfd View All
Sanofi	6	Healx, Hummingbird Bioscience, asddswdsfd , asddswdsfd View All
Eli Lilly and Company	5	GeneDX, Inspire, asddswdsfd , asddswdsfd View All
Merck KGaA	5	Hummingbird Bioscience, Ad Scientiam, asddswdsfd , asddswdsfd View All
Stanford University	5	Immunai, Atropos Health, asddswdsfd , asddswdsfd View All
MSD	5	Hummingbird Bioscience, Atropos Health, asddswdsfd , asddswdsfd View All

Showing 1 to 10 of 338 entries